MRNS - Marinus Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5232.61M
Enterprise Value 3185.43M
Trailing P/E N/A
Forward P/E 1-5.98
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)5.17
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-7.52

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-43.86%
Return on Equity (ttm)-79.64%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -24.67M
Net Income Avi to Common (ttm)-24.41M
Diluted EPS (ttm)-0.74
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)46.37M
Total Cash Per Share (mrq)1.14
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)13.32
Book Value Per Share (mrq)1.11

Cash Flow Statement

Operating Cash Flow (ttm)-19.48M
Levered Free Cash Flow (ttm)-10.8M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.88
52-Week Change 312.16%
S&P500 52-Week Change 37.73%
52 Week High 310.54
52 Week Low 33.31
50-Day Moving Average 37.46
200-Day Moving Average 36.47

Share Statistics

Avg Vol (3 month) 3661.16k
Avg Vol (10 day) 3669.88k
Shares Outstanding 540.52M
Float 32.67M
% Held by Insiders 11.14%
% Held by Institutions 171.71%
Shares Short (Sep 28, 2018) 44.03M
Short Ratio (Sep 28, 2018) 45.63
Short % of Float (Sep 28, 2018) 410.73%
Short % of Shares Outstanding (Sep 28, 2018) 49.93%
Shares Short (prior month Aug 31, 2018) 43.82M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A